about
From integrative genomics to therapeutic targetsRole of n-3 Polyunsaturated Fatty Acids and Exercise in Breast Cancer Prevention: Identifying Common TargetsPotential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesisIdentification of Biomarkers for Breast Cancer Using Databases.A Role for Histone H2B Variants in Endocrine-Resistant Breast Cancer.Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancerNuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer.An epigenomic approach to therapy for tamoxifen-resistant breast cancerPhytoestrogens and prevention of breast cancer: The contentious debateTGF-β mediated DNA methylation in prostate cancer.PIAS1 regulates breast tumorigenesis through selective epigenetic gene silencingHierarchical clustering of breast cancer methylomes revealed differentially methylated and expressed breast cancer genes.Bi-phasic expression of Heterochromatin Protein 1 (HP1) during breast cancer progression: Potential roles of HP1 and chromatin structure in tumorigenesis.A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer.Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down-regulating EGFR expression.Role of epigenetic modifications in luminal breast cancer.Epigenetic changes in cancer by Raman imaging, fluorescence imaging, AFM and scanning near-field optical microscopy (SNOM). Acetylation in normal and human cancer breast cells MCF10A, MCF7 and MDA-MB-231.Epigenetic mechanisms in commonly occurring cancers.Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth.The genomic landscape of breast cancer as a therapeutic roadmapCDH1 promoter methylation correlates with decreased gene expression and poor prognosis in patients with breast cancer.Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.Epigenetic mechanisms in penile carcinoma.A Catalogue of Altered Salivary Proteins Secondary to Invasive Ductal Carcinoma: A Novel In Vivo Paradigm to Assess Breast Cancer ProgressionIdentification of a Novel lincRNA-p21-miR-181b-PTEN Signaling Cascade in Liver Fibrosis.Elevated expression of RNA methyltransferase BCDIN3D predicts poor prognosis in breast cancer.Epigenetic activation of LY6K predicts the presence of metastasis and poor prognosis in breast carcinoma.SET domain-containing Protein 4 (SETD4) is a Newly Identified Cytosolic and Nuclear Lysine Methyltransferase involved in Breast Cancer Cell Proliferation.Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer.Epigenetic reprogramming in breast cancer: from new targets to new therapies.miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development.Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells.Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11-p12-amplified breast carcinomas.NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6.ASXL2 promotes proliferation of breast cancer cells by linking ERα to histone methylation.Combinatorial epigenetic mechanisms and efficacy of early breast cancer inhibition by nutritive botanicals.Targeting tumorigenicity of breast cancer stem-like cells using combination epigenetic therapy: something old and something newEpigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer.Breast cancer: current state and future promise
P2860
Q26862726-A2730D9F-7563-46AA-B3C2-94769F103625Q28066027-77A93F23-E2D0-4D28-ABB5-B9BFC95AE5BFQ28393302-1A453A0A-91C0-4193-9D33-B8C10265DCFBQ30239810-5042F1E7-A419-4D93-8DD5-4B708A9D3EC8Q30355029-83B6081D-A687-4C98-B4D9-D78CCB278023Q30408963-777DB54C-6DB9-4D01-836B-6541EE95A9A0Q33588369-90DB8399-31DB-4EEB-BDB0-33FDE43018A9Q33859350-00040F58-43B8-44FA-81B1-C8DBF1755B34Q34031258-10BC2B90-357D-4A9B-9071-E4D3B9A90700Q34039935-6A35C1EC-ECBD-4C61-B9F9-F21F42F8368DQ35107382-B0A2FB9F-6E60-484D-9DD9-02377141CB7DQ35113247-B1725B38-4A61-4D08-BD38-839FD4EB450AQ35737313-332D63F1-796F-4A84-9A88-48F4793D9FA2Q35886083-F3783535-C3A3-4AE6-B458-943CD761B061Q35911749-F0165E21-E671-4912-839E-E471751084BFQ35963443-AE0EEC7A-3283-48F0-904A-DEB19DA51036Q36086535-56421E7A-80B9-4B23-A669-07074DADA18CQ36286662-A6C92D39-9E4D-4637-A6FA-4609E8F1A132Q36355895-E319B628-E711-46F0-AC79-DECE349A4916Q36558069-75609E55-FD23-4EBA-B46B-707356BC06E2Q36741554-2F8AFA7C-A522-4F02-9B5F-DACC9034D3A6Q36895363-2F60005C-D331-46A8-88E0-268C1EF2691DQ37007058-8B0B8BC8-FC89-4B85-BBD9-DD4DA5AC43E8Q37141148-6217E2C5-3A1C-4344-A4EF-9298D77508BBQ37215410-FF57E24B-70B7-4ACD-98DB-5AF4051B8C46Q37619842-32BEBE1C-B64B-453B-B48A-7BBEE0F02AB7Q37688300-3613D8F9-65FB-44AE-9249-80CBF0B0C911Q37699803-A7D2531E-6A3C-4601-BB26-6988803F9491Q38081505-9707C4AA-0D99-4075-AE69-80C4EE0C9A58Q38233472-0AC0BA0A-BD48-4E06-B9BB-2CC04AD2CA82Q38739495-CE926FC1-4C06-4F97-9A42-5C478B263FD7Q38769263-C03A2200-164C-4974-9CDA-3C421FF454BAQ38985398-597BA334-F5FD-4B80-B426-D24EE0D21F31Q40058161-C355DB7B-57CB-4F82-9956-71F99EAC4958Q40070033-4E11EBBC-1E44-4B69-84A0-6F4EC1435EA6Q41071413-CAFCCA95-52BB-4A63-9EA7-C8E3F169AD64Q41473798-5605E425-9835-4376-A8BB-89A17B566344Q42344266-557ECECD-664D-430A-AA24-911EF4CB2BB2Q42367979-0C0F8171-228D-49A3-A97C-169E73599AB5Q42546056-7269147A-752E-412A-A777-9AA3B0FEE8B7
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Epigenetics in breast cancer: what's new?
@ast
Epigenetics in breast cancer: what's new?
@en
Epigenetics in breast cancer: what's new?
@nl
type
label
Epigenetics in breast cancer: what's new?
@ast
Epigenetics in breast cancer: what's new?
@en
Epigenetics in breast cancer: what's new?
@nl
prefLabel
Epigenetics in breast cancer: what's new?
@ast
Epigenetics in breast cancer: what's new?
@en
Epigenetics in breast cancer: what's new?
@nl
P2093
P2860
P921
P3181
P356
P1476
Epigenetics in breast cancer: what's new?
@en
P2093
Nancy E Davidson
Rachel Jankowitz
Shweta Nayak
Steffi Oesterreich
P2860
P2888
P3181
P356
10.1186/BCR2925
P407
P577
2011-01-01T00:00:00Z
2011-11-01T00:00:00Z
P5875
P6179
1052017109